N. Kelepouris

发表

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY.

A. J. van der Lely, P. Freda, M. Gordon, 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database

A. Hoffman, M. Fleseriu, D. Clemmons, 2022, International journal of endocrinology.

Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients’ Perspective

A. Hoffman, M. Fleseriu, N. Kelepouris, 2022, Journal of the Endocrine Society.

Sensitivity and specificity of the macimorelin test for diagnosis of AGHD.

P. Chanson, M. Korbonits, C. Strasburger, 2020, Endocrine connections.

Hemifacial spasm and osteitis deformans

R. Sergott, P. Savino, T. Bosley, 1995 .

A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury

B. Masel, M. Jaffee, R. Urban, 2022, Growth Hormone & IGF Research.

ALL-CAUSE MORTALITY IN PATIENTS WITH ACROMEGALY TREATED WITH PEGVISOMANT AN ACROSTUDY ANALYSIS.

A. Klibanski, N. Tritos, B. Biller, 2020, European journal of endocrinology.

Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status

M. Maghnie, M. Zenker, R. Horikawa, 2022, Endocrine connections.

Estradiol Down-Regulation of the Rat Uterine Estrogen Receptor

D M Sheehan, C. Lyttle, D. Sheehan, 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Hemifacial spasm and osteitis deformans.

R. Sergott, P. Savino, T. Bosley, 1996, American journal of ophthalmology.

Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER

M. Polak, P. Backeljauw, T. Rohrer, 2021, The Journal of clinical endocrinology and metabolism.

Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis

P. Backeljauw, T. Rohrer, M. Fridman, 2023, Journal of the Endocrine Society.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of macimorelin in healthy adults: Results of a single-dose, randomized controlled study.

Vlady Ostrow, R. Sachse, N. Kelepouris, 2020, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Adult growth hormone deficiency: Optimizing transition of care from pediatric to adult services.

C. Alter, S. Samson, K. Yuen, 2020, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study

M. Tauber, Vlady Ostrow, A. Pietropoli, 2020, International Journal of Pediatric Endocrinology.

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

P. Carroll, B. Biller, C. Höybye, 2021, Pituitary.

Thorough QT/QTc Study Evaluating the Effect of Macimorelin on Cardiac Safety Parameters in Healthy Participants

Vlady Ostrow, R. Sachse, N. Kelepouris, 2020, Clinical pharmacology in drug development.

Severe Osteoporosis in Men

F. Gannon, F. Kaplan, K. Harper, 1995, Annals of Internal Medicine.

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence

J. Kaski, T. Rohrer, J. Dahlgren, 2021, Endocrine connections.

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

B. Biller, C. Höybye, Jean-Marc Ferran, 2023, Journal of the Endocrine Society.

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

B. Biller, C. Höybye, Jean-Marc Ferran, 2022, Endocrine connections.

SUN-LB080 ACROSTUDY - Safety and Efficacy of a Cohort of 110 Naïve Patients with Acromegaly Treated with Pegvisomant

M. Fleseriu, R. Salvatori, T. Brue, 2019, Journal of the Endocrine Society.

Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study

N. Kelepouris, Javier Cárdenas, Radhika Adiga, 2024, BMC medical education.

Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency.

N. Kelepouris, Georgiana Dobri, Bradley S. Miller, 2024, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.